Dyne Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $14.0M | $14.6M |
| FY2020 | — | $342.4M | $300.9M |
| FY2021 | — | $368.2M | $200.8M |
| FY2022 | — | $252.4M | $172.1M |
| FY2023 | — | $91.3M | $121.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $14.0M | $14.6M |
| FY2020 | — | $342.4M | $300.9M |
| FY2021 | — | $368.2M | $200.8M |
| FY2022 | — | $252.4M | $172.1M |
| FY2023 | — | $91.3M | $121.6M |